Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
StandardStandard
Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. / Hughes, D.; Hughes, D.A.
2002 gol. Unknown, 2002.
2002 gol. Unknown, 2002.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
HarvardHarvard
Hughes, D & Hughes, DA 2002, Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. 2002 gol., Unknown.
APA
Hughes, D., & Hughes, D. A. (2002). Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. (2002 gol.) Unknown.
CBE
Hughes D, Hughes DA 2002. Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. 2002 gol. Unknown.
MLA
Hughes, D. a D.A. Hughes Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. 2002 udg. Unknown. 2002.
VancouverVancouver
Hughes D, Hughes DA. Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations. 2002 gol. Unknown, 2002.
Author
RIS
TY - BOOK
T1 - Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations.
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2002/1/1
Y1 - 2002/1/1
M3 - Commissioned report
BT - Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations.
PB - Unknown
ER -